We are proud to announce the closing of the 540 million dirham capital increase in our subsidiary Dislog Dispositifs Médicaux (DDM), with the participation of Mediterrania. Capital Partners and CDG Invest Growth. This fund-raising - the largest in our history - marks a decisive turning point in the development of our healthcare division.
In less than six months, we have integrated several key players in the medical sector into DDM: MEGAFLEX, ERAMEDIC, AFROBIOMEDIC, FARMALAC, and very soon a fifth entity. This ambitious project is being carried out rigorously, in the spirit of our Build & Run model, to create an integrated, expert and structured player in medical devices.
This operation fully illustrates our ability to aggregate, structure and leverage synergies in high-impact sectors, while generating value for all our shareholders.
A big thank you to the teams involved and to our partners for their confidence.